Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP549341.RAWbkAGQW0boef-grZCNgMG_KSO6yLci6Sdxsa0p_uCbQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP549341.RAWbkAGQW0boef-grZCNgMG_KSO6yLci6Sdxsa0p_uCbQ130_assertion type Assertion NP549341.RAWbkAGQW0boef-grZCNgMG_KSO6yLci6Sdxsa0p_uCbQ130_head.
- NP549341.RAWbkAGQW0boef-grZCNgMG_KSO6yLci6Sdxsa0p_uCbQ130_assertion description "[These data provide further evidence that modulators of the NPY Y2 receptor subtype are drug targets for the treatment of anxiety and mood disorders in human subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549341.RAWbkAGQW0boef-grZCNgMG_KSO6yLci6Sdxsa0p_uCbQ130_provenance.
- NP549341.RAWbkAGQW0boef-grZCNgMG_KSO6yLci6Sdxsa0p_uCbQ130_assertion evidence source_evidence_literature NP549341.RAWbkAGQW0boef-grZCNgMG_KSO6yLci6Sdxsa0p_uCbQ130_provenance.
- NP549341.RAWbkAGQW0boef-grZCNgMG_KSO6yLci6Sdxsa0p_uCbQ130_assertion SIO_000772 16691011 NP549341.RAWbkAGQW0boef-grZCNgMG_KSO6yLci6Sdxsa0p_uCbQ130_provenance.
- NP549341.RAWbkAGQW0boef-grZCNgMG_KSO6yLci6Sdxsa0p_uCbQ130_assertion wasDerivedFrom befree-2016 NP549341.RAWbkAGQW0boef-grZCNgMG_KSO6yLci6Sdxsa0p_uCbQ130_provenance.
- NP549341.RAWbkAGQW0boef-grZCNgMG_KSO6yLci6Sdxsa0p_uCbQ130_assertion wasGeneratedBy ECO_0000203 NP549341.RAWbkAGQW0boef-grZCNgMG_KSO6yLci6Sdxsa0p_uCbQ130_provenance.